• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of long-term effects of medical implants >An expanded surgical suture and needle evaluation and selection program by a healthcare resource management group purchasing organization.
【24h】

An expanded surgical suture and needle evaluation and selection program by a healthcare resource management group purchasing organization.

机译：通过医疗资源管理组采购组织进行扩展的手术缝合线和针头评估和选择计划。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

The purpose of this report is to describe an expanded suture and needle clinical evaluation program jointly designed by hospital representatives of Consorta, Inc. (Rolling Meadows, Illinois), a leading healthcare resource management and group purchasing organization, and United States Surgical/Davis & Geck Sutures (Division of United States Surgical, Norwalk, Connecticut). In this expanded evaluation program, 42 Consorta shareholder hospitals enrolled 1913 surgeons to participate in Phase II of this non-experimental observational study of the clinical performance of surgical needles and sutures. Performance characteristics of the sutures and needles produced by USS/DG that were evaluated in 25,545 surgical procedures included packaging/ease of opening, needle strength and sharpness, tissue drag, knot security, tensile strength, clinically acceptable determinations, and clinically unacceptable determinations. In these 30-day studies, the surgeons found that the needles and sutures were clinically acceptable in 98.1% of the evaluations. The general, cardiothoracic, and orthopedic surgeons who performed 61.2% of the product evaluations reported that the suture and needle products were clinically acceptable in 98.2% of the evaluations. Nearly half (49.2%) of the evaluations involved the POLYSORB* braided synthetic sutures that received a clinically acceptable rating in 98.2% of the evaluation. The silk suture (SOFSILK*), followed by the monofilament nylon suture (MONOSOF*), were the next most frequently used sutures. The SOFSILK* was found to be clinically acceptable in 99.2% of the evaluations, while MONOSOF* was noted to be clinically acceptable in 98.7% of the evaluations. Surgical needles made by USS/DG Sutures also had a high rating of clinical acceptability (97.9%).
机译：本报告的目的是描述由Consorta，Inc。（滚动Meadows，Illinois），领先的医疗资源管理和集团采购组织以及美国外科/戴维斯和美国外科/戴维斯的医院代表联合设计的扩展缝合和针临床评估计划Geck Sutures（美国外科手术，诺沃克，康涅狄格州）。在这一扩大的评估计划中，42家联邦股东医院注册了1913年外科医生，参与了这种非实验性观察研究的II期，对手术针和缝合线的临床表现。由USS / DG生产的缝合线和针头的性能特征在25,545外科手术中进行了评估，包括打开，针强度和清晰度，组织阻力，结安，抗拉强度，临床上可接受的测定和临床不可接受的测定的包装/易用性。在这30天的研究中，外科医生发现，在98.1％的评估中，针和缝合线在临床上可以接受。进行61.2％的产品评估的一般，心胸和矫形外科医生报告说，缝合和针产品在98.2％的评估中临床上可接受。近一半（49.2％）的评估涉及Polysorb *编织合成缝合线，在98.2％的评估中获得了临床上可接受的评级。丝绸缝线（Sofsilk *），其次是单丝尼龙缝合线（Monosof *），是下一个最常用的缝合线。发现Sofsilk *在99.2％的评估中被发现在临床上可以接受，而Monosof *则注意到在98.7％的评估中临床上可接受。 USS / DG缝合线制造的手术针也具有高临床可接受性（97.9％）的额定值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号